echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Medical News > Medicines Company News > Tianyao Pharmaceutical's chairman, some directors and general managers resign

    Tianyao Pharmaceutical's chairman, some directors and general managers resign

    • Last Update: 2021-07-06
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

    On the 16th, Tianyao Pharmaceutical announced that the company’s board of directors received written resignation applications from Mr.
    Zhang Jie, Mr.
    He Guangjie and Mr.
    Yang Fuzhen on June 15, 2021
    .

    Due to job changes, Mr.
    Zhang Jie applied to resign from the company’s eighth board of directors and directors, Mr.
    He Guangjie applied to resign from the company’s eighth board of directors and convener of the strategy committee, and Mr.
    Yang Fuzhen applied to resign from the company’s eighth board of directors and general manager Position
    .


    Mr.


    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Related Articles

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.